Literature DB >> 3133557

The IgG1 subclass preference of selected, naturally occurring antipolysaccharide antibodies.

L Hammarström1, R A Insel, M A Persson, C I Smith.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3133557

Source DB:  PubMed          Journal:  Monogr Allergy        ISSN： 0077-0760


× No keyword cloud information.
  7 in total

1.  Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.

Authors:  M Tomana; J Novak; B A Julian; K Matousovic; K Konecny; J Mestecky
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

2.  Antilipopolysaccharide antibodies and differential diagnosis of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.

Authors:  A Fomsgaard; B Dinesen; G H Shand; T Pressler; N Høiby
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

3.  Severity of infections in IgA deficiency: correlation with decreased serum antibodies to pneumococcal polysaccharides and decreased serum IgG2 and/or IgG4.

Authors:  M A French; K A Denis; R Dawkins; J B Peter
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

4.  Increases in the levels of Coxiella burnetii-specific immunoglobulin G1 and G3 antibodies in acute Q fever and chronic Q fever.

Authors:  C Capo; I Iorgulescu; M Mutillod; J L Mege; D Raoult
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

5.  Role of immunoglobulin G subclasses in Q fever.

Authors:  M T Camacho; I Outschoorn; A Tellez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-12       Impact factor: 3.267

6.  The influence of genetic factors on the immune response as judged by pneumococcal vaccination of mono- and dizygotic Caucasian twins.

Authors:  H B Konradsen; J Henrichsen; H Wachmann; N Holm
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

Review 7.  Immunoglobulin G subclass deficiency: fact or fancy?

Authors:  Rebecca H Buckley
Journal:  Curr Allergy Asthma Rep       Date:  2002-09       Impact factor: 4.919
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.